The Calquence Market is on the rise, projected to reach USD 4.3 billion by 2030 with a CAGR of 10.5%. This surge is driven by increased blood cancer cases, expanding clinical applications, and improved healthcare infrastructure worldwide. As targeted therapies like Calquence gain traction, the market continues to grow, especially across North America and the Asia-Pacific region. Want to dive deeper into the market dynamics and growth potential? Access our detailed report now! https://marksparksolutions.com/reports/global-calquence-market-insights #CalquenceMarket #acalabrutinibMarketSize #GlobalCalquenceMarket #CancerTreatment #HealthcareInsights #MarketGrowth #PharmaceuticalTrends #MarkAndSparkSolutions